A recent study suggests that patients who discontinue popular slimming jabs like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise regimens.
Research printed in a prominent health publication shows that while overweight people can lose a large proportion of their body weight while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing such drugs should be cognizant of the potential of rapid weight regain when the therapy ends," cautioned expert Dr. Susan Jebb.
Such speed of recovery implies a reversion to original weight in about one and a half years.
Comparing Approaches
The analysis, which examined dozens of trials involving thousands of participants, contrasted the results of GLP-1 agonists with other pills.
The team emphasize that people who lose weight through dieting usually experience a more gradual creep back—approximately 100 grams monthly—once they finish.
Understanding the Fast Regain
Experts suggest the mode of action of the jabs explains the accelerated rebound.
GLP-1 drugs copy a body's own chemical called GLP-1, which helps regulate appetite.
"Long-term administration of GLP-1 concentrations far above than the body's typical production could lead to the body to produce less of its own natural hormone, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement means hunger is no longer kept in check, making overeating much more probable."
A Lifelong Disease?
Medical guidelines recommend the jabs for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.
Professionals say that, considering the significant potential of relapse, the therapy might need to be life-long.
This opinion is echoed by pharmaceutical companies, who state that the findings "highlight the persistent nature of obesity," akin to managing diseases like high blood pressure.
User Testimonies
Users who have discontinued the jabs describe a powerful return of cravings.
"It felt as if something that goes on and you're instantly starving," recalled an individual.
The struggle is compounded if individuals have not developed sustainable dietary or behavioural modifications during treatment.
Significant Adoption
Recent estimates suggest that millions of people in the UK have tried weight-loss jabs in the past year, with demand being substantial.
- Use is higher among females than males.
- The middle-aged demographic shows the greatest usage rates.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, experts stress that while these medications are effective agents for shedding pounds, they are not a standalone fix and lasting health benefits relies on integrated lifestyle support.